BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perumareddi P, Trelka DP. Autosomal Dominant Polycystic Kidney Disease. Prim Care 2020;47:673-89. [PMID: 33121636 DOI: 10.1016/j.pop.2020.08.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Wang B, Li D, Li J, Luo Y, Dan J. Roles of telomeres and telomerase in age‑related renal diseases (Review). Mol Med Rep 2021;23:96. [PMID: 33300081 DOI: 10.3892/mmr.2020.11735] [Reference Citation Analysis]
2 Ermurat S, Güllülü M, Sarandöl E. The effects of the renin–angiotensin–aldosterone system blockers on serum ischemia-modified albumin levels in autosomal dominant polycystic kidney disease. Ir J Med Sci. [DOI: 10.1007/s11845-022-02925-y] [Reference Citation Analysis]
3 Liu J, Fujikura K, Dev H, Riyahi S, Blumenfeld J, Kim J, Rennert H, Prince MR. Pericardial Effusion on MRI in Autosomal Dominant Polycystic Kidney Disease. J Clin Med 2022;11:1127. [PMID: 35207400 DOI: 10.3390/jcm11041127] [Reference Citation Analysis]